Further, analysis of the correlation between GAD1 and the prostate cancer immune microenvironment indicated that GAD1 expression and methylation were significantly associated with many immune indicators, including lymphocytes, immunoinhibitors, immunostimulators, MHC molecules, chemokines and chemokine receptors. This evidence concerns the gene HLA-C and prostate carcinoma.